Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intervention with tadalafil for recovery of sexual function after rectal cancer treatment
2017-004916-21Phase 2Active
- Sponsor
- Karolinska Institutet
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tadalafil in rectal cancer, sexual dysfunction and erectile dysfunction (ED) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Primary - change in female sexual function (FSFI-6 total score). Started Jan 2019; status: active.
02
Drugs
tadalafil
03
Conditions
rectal cancersexual dysfunctionerectile dysfunction (ED)
Beyond the preview
Go deeper on 2017-004916-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004916-21.